Who may be eligible to participate?
– Adults older than 40 years old who suffer from IPF
– Previously been diagnosed with mild to moderate IPF
– Not on Nintedanib or Pirfenidone within 30 days prior to enrolment in study
Send us your details. We will be in touch.
